热景生物：累计回购约90万股

Group 1 - The core point of the news is that 热景生物 has repurchased approximately 900,000 shares, which is about 0.98% of its total share capital, with a total expenditure of approximately 150 million RMB [1] - The share repurchase was conducted through centralized bidding, with the highest transaction price being 176.79 RMB per share and the lowest at 145.59 RMB per share [1] - As of the announcement date, the market capitalization of 热景生物 is 15.2 billion RMB [2] Group 2 - For the fiscal year 2024, the revenue composition of 热景生物 is primarily from in vitro diagnostic products, accounting for 98.85%, while other businesses contribute 1.15% [1]